Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study is to assess the efficacy of bupropion in reducing methamphetamine use in subjects
with methamphetamine dependence who report using methamphetamine 29 or less days during the
30 days prior to the start of signing consent.